Columbus McKinnon Details Transformational Kito Crosby Acquisition Financing & Pro Forma Financials
Summary
Columbus McKinnon provided preliminary Q3 2025 financial results and extensive details on the financing for its $2.7 billion acquisition of Kito Crosby, including pro forma financials and a high initial leverage ratio.
Key Events
-
Preliminary Q3 2025 Financial Results
Columbus McKinnon reported preliminary Q3 2025 net sales ranging from $250 million to $260 million and Adjusted EBITDA from $38 million to $40 million, with Adjusted EPS between $0.58 and $0.63.
-
Kito Crosby Acquisition Financing Details
The company disclosed plans for up to $2.55 billion in new debt financing and an $800 million perpetual convertible preferred equity investment to fund the $2.7 billion Kito Crosby acquisition.
-
Pro Forma Financials and High Leverage
The combined company is projected to have approximately $2.0 billion in annual net sales and a pro forma Adjusted EBITDA of $429 million, but with an initial net leverage ratio of 5.5x.
-
Preliminary Kito Crosby & Divestiture Financials
Preliminary estimated financials for Kito Crosby (FY25 net sales $1.13B-$1.14B, Adjusted EBITDA $268M-$275M) and the Divestiture Business (Q3 2025 net sales $33M-$36M, Adjusted EBITDA $10M-$15M) were provided.
Analysis
This filing is critical as it outlines the financial structure and impact of Columbus McKinnon's transformational $2.7 billion acquisition of Kito Crosby, a deal significantly larger than CMCO's current market capitalization. While the acquisition is strategically positioned to enhance scale and market leadership, the proposed financing involves substantial new debt, resulting in a high initial net leverage ratio of 5.5x. Investors should closely monitor the company's ability to achieve the projected synergies and rapidly de-leverage, as this will be crucial for long-term value creation given the increased financial risk.
At the time of this filing, CMCO was trading at $20.18 on NASDAQ in the Technology sector, with a market capitalization of approximately $575.4M. The 52-week trading range was $11.78 to $37.81. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.